490 related articles for article (PubMed ID: 12669271)
21. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
22. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
[TBL] [Abstract][Full Text] [Related]
23. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
Jehle PM; Jehle D; Fussgänger RD; Adler G
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
[TBL] [Abstract][Full Text] [Related]
24. Effects of glucagon-like peptide-1-(7-36)-amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK rats.
Svensson AM; Ostenson CG; Efendic S; Jansson L
Clin Sci (Lond); 2007 Jun; 112(6):345-51. PubMed ID: 17087662
[TBL] [Abstract][Full Text] [Related]
25. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
Zawalich WS; Zawalich KC
Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
[TBL] [Abstract][Full Text] [Related]
26. Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.
Salehi A; Meidute Abaraviciene S; Jimenez-Feltstrom J; Ostenson CG; Efendic S; Lundquist I
PLoS One; 2008 May; 3(5):e2165. PubMed ID: 18478125
[TBL] [Abstract][Full Text] [Related]
27. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
29. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
Inoue K; Hisatomi A; Umeda F; Nawata H
Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
[TBL] [Abstract][Full Text] [Related]
30. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.
Sjöholm A; Sandberg E; Ostenson CG; Efendić S
Pancreas; 2000 Apr; 20(3):282-9. PubMed ID: 10766455
[TBL] [Abstract][Full Text] [Related]
31. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
32. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
[TBL] [Abstract][Full Text] [Related]
33. Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat.
Bourlon PM; Faure-Dussert A; Billaudel B
Br J Pharmacol; 1997 Jun; 121(4):751-8. PubMed ID: 9208144
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expression of neuronal nitric oxide synthase in islets of exercise-trained rats.
Ueda H; Urano Y; Sakurai T; Kizaki T; Hitomi Y; Ohno H; Izawa T
Biochem Biophys Res Commun; 2003 Dec; 312(3):794-800. PubMed ID: 14680835
[TBL] [Abstract][Full Text] [Related]
35. Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids.
Abrahamsen N; Nishimura E
Endocrinology; 1995 Apr; 136(4):1572-8. PubMed ID: 7534705
[TBL] [Abstract][Full Text] [Related]
36. Impaired glucose-stimulated insulin secretion in the GK rat is associated with abnormalities in islet nitric oxide production.
Mosén H; Ostenson CG; Lundquist I; Alm P; Henningsson R; Jimenez-Feltström J; Guenifi A; Efendic S; Salehi A
Regul Pept; 2008 Nov; 151(1-3):139-46. PubMed ID: 18662725
[TBL] [Abstract][Full Text] [Related]
37. Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.
García-Flores M; Zueco JA; Alvarez E; Blázquez E
Eur J Biochem; 2001 Feb; 268(3):514-20. PubMed ID: 11168389
[TBL] [Abstract][Full Text] [Related]
38. Defective insulin secretion during total parenteral nutrition in rat and its normalization by pituitary adenylate cyclase-activating polypeptide 27.
Salehi A; Qader SS; Ekblad E; Ekelund M
Regul Pept; 2004 Jun; 119(1-2):83-91. PubMed ID: 15093701
[TBL] [Abstract][Full Text] [Related]
39. Correlation between GABA release from rat islet beta-cells and their metabolic state.
Winnock F; Ling Z; De Proft R; Dejonghe S; Schuit F; Gorus F; Pipeleers D
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E937-42. PubMed ID: 11882516
[TBL] [Abstract][Full Text] [Related]
40. Constitution of a biphasic insulin response to glucose in human fetal pancreatic beta-cells with glucagon-like peptide 1.
Otonkoski T; Hayek A
J Clin Endocrinol Metab; 1995 Dec; 80(12):3779-83. PubMed ID: 8530635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
